Abstract

Internet of Things (IoT) is an interrelated system of computing devices, machines, sensors, and objects. It can transfer data over a network without the Human-to-computer or Human-to human interaction. This article is focused on the progression in IoT. It was analyzed that how IoT can truly revolutionize the oppositions faced by Manufacturing, Logistics, and Supply chain logistics in the pharmaceutical industry during the Covid-19 pandemic and following. In the present scenario of this pandemic and annihilation, IoT has emerged as the need of the time for the pharmaceutical industries. In order to develop a well-coordinated logistic and supply chain network, it is required to make their prominent occupancy in the market. Patients are unavailable for the essential medicines and medications that are critical and strong to protect. With the current and recent developments in automation technology, the need for consistency of supply chain visibility in the pharmaceutical industries has increased enormously. The implementation of these automation technologies will certainly result in getting serious confidence in understanding the statistics of the supply chain. This technology is also built to invalidate the risk factors that accompany the pharmaceutical supply chain network. Generally, these systems are available and operate as a decentralized system. The information or data transmitted via these systems is isolated and the protection of vulnerable data is therefore not compromised.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.